Keep up-to-date on the latestpsoriatic arthritis (PsA) researchwith our brief research summaries.
PsA Increases Diabetes Risk
Having PsA may increase yourrisk of diabetes, according to recent research. In a study of 1,305 PsA patients seen in a large specialty clinic between January 1978 and November 2014, Canadian researchers found their risk of developing diabetes was 43% higher than for the general population. The risk was greatest among those with the highest levels of PsA activity, suggesting inflammation may be a common thread in the two diseases.
Source:The Journal of Rheumatology, published online February 2017
Stopping Biologics Before Surgery
Stoppingbiologicsmonths before elective surgery may not be necessary to reduce infection risk as was once believed. In a study of 4,288 patients who underwent elective hip or knee surgery, stopping infliximab just 4 weeks before surgery presented no more infection risk than stopping the drug 8 to 12 weeks before surgery. The patients were receiving infliximab for one of several diagnoses includingPsA,rheumatoid arthritisandankylosing spondylitis.
Source:Arthritis Care & Research, published online January 2017
Fibromyalgia Complicates PsA
Living with PsA can be hard, but havingfibromyalgia最近的一项研究表明，PsA可能更难。以色列研究人员评估了73名PsA患者的疾病活动度和生活质量的几个指标，其中13人被确定同时患有纤维肌痛。与单独PsA组相比，纤维肌痛患者在一般健康指标上得分较低，在疾病活动度指标上得分较高。这些发现表明，在设计PsA的治疗方案时，纤维肌痛应被考虑在内。
Source:The Journal of Rheumatology, September 2016
Related Resources:
- Psoriatic Arthritis Research Briefs: Nail Changes, New Biologic, Biosimilar
Psoriatic Arthritis Research Briefs: Disease Burden, Eye Surgery, New Biologic